Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom to Establish MassArray Haplotyping Facility at Genaissance


SAN DIEGO--Sequenom announced that it will install its MassArray genotyping system as the platform for the high-throughput haplotyping facility at Genaissance Pharmaceuticals, a population genomics and informatics company in New Haven, Conn. The agreement follows an initial MassArray system placement at Genaissance, which will now purchase at least two additional units.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.